Search - tctmd.com

Displaying 121 - 140 of 1109

Sort: Relevancy | Date

News Daily News

Rivaroxaban May Help Dissolve Left Atrial Thrombus in Patients With A-fib

Todd Neale

June 09, 2016

News Daily News

Equivalent Mortality at 30 Days and 1 Year With TAVR vs Surgery, Says Large Meta-analysis

Michael O'Riordan

June 07, 2016

News Conference News EAS 2016

Statin-Associated Muscle Symptoms: Real or ‘Artificial,’ Physicians Should Take Time to Manage Patients

Yael L. Maxwell

June 01, 2016

News Industry News

BIOTRONIK Launches CardioMessenger Smart Portable Device For Pacemaker and ICD Patients

May 24, 2016

Presentation EuroPCR 2016

Effect of DAPT Termination at 12 Months on Very Late scaffold thrombosis in regular clinical practice: Data of a regional collaboration

Presenter: Robert-Jan van Geuns

May 18, 2016

News Conference News EuroPCR 2016

Reassuring Registry Data Suggest Scaffold Thrombosis Rates with BVS Declining

Michael O'Riordan

May 17, 2016

News Conference News EuroPCR 2016

Not Necessarily PERFECT, but Drug-Eluting Balloon Shows Promise for Erectile Dysfunction

Yael L. Maxwell

May 17, 2016

News Conference News SCAI 2016

Risk-Treatment Paradox Unfortunately Alive and Well Among Young Women with ACS

L.A. McKeown

May 13, 2016

News Daily News

Treatment Duration May Explain Inconsistent Risks Seen With Testosterone Therapy

Caitlin E. Cox

May 12, 2016

News Daily News

重新认证考试是否临近终结？ABIM 公布第二次家中评估选项

Yael L. Maxwell

May 09, 2016

News Daily News

¿Está Cerca el Fin de los Exámenes de Re-certificación? ABIM Anuncia una 2ª Opción de Evaluación en Casa

Yael L. Maxwell

May 09, 2016

News Daily News

Is the End of Recertification Exams Near? ABIM Announces At-Home Assessment Option

Yael L. Maxwell

May 09, 2016

News Daily News

STICS: No Benefit to Perioperative Statin Therapy in Cardiac Surgery, but Acute Kidney Injury Risk Increased

Michael O'Riordan

May 05, 2016

News Industry News

BIOTRONIK Announces FDA Approval of MR Conditional Cardiac Resynchronization Defibrillators

May 04, 2016

News Features

The Heart Team: What Works, What Doesn’t, and What the Future Holds

Yael L. Maxwell

May 03, 2016

News Daily News

Un Estudio del Mundo Real Confirma los Efectos de Apixaban y Rivaroxaban en el Manejo de la FA

Todd Neale

April 21, 2016

News Daily News

Real-World Study Largely Confirms Effects of Apixaban, Rivaroxaban for A-fib

Todd Neale

April 21, 2016

News Daily News

Low BMI in and of Itself Portends Poor Survival After Acute MI

Caitlin E. Cox

April 21, 2016

News Daily News

Good Warfarin Management Prevents Complications in A-fib Patients, Swedish Study Contends

L.A. McKeown

April 21, 2016

News Features

We Asked, You Answered: The Heart Team by the Numbers

Yael L. Maxwell

April 13, 2016

Advertisement

Rivaroxaban May Help Dissolve Left Atrial Thrombus in Patients With A-fib

Equivalent Mortality at 30 Days and 1 Year With TAVR vs Surgery, Says Large Meta-analysis

Statin-Associated Muscle Symptoms: Real or ‘Artificial,’ Physicians Should Take Time to Manage Patients

BIOTRONIK Launches CardioMessenger Smart Portable Device For Pacemaker and ICD Patients

Effect of DAPT Termination at 12 Months on Very Late scaffold thrombosis in regular clinical practice: Data of a regional collaboration

Reassuring Registry Data Suggest Scaffold Thrombosis Rates with BVS Declining

Not Necessarily PERFECT, but Drug-Eluting Balloon Shows Promise for Erectile Dysfunction

Risk-Treatment Paradox Unfortunately Alive and Well Among Young Women with ACS

Treatment Duration May Explain Inconsistent Risks Seen With Testosterone Therapy

重新认证考试是否临近终结？ABIM 公布第二次家中评估选项

¿Está Cerca el Fin de los Exámenes de Re-certificación? ABIM Anuncia una 2ª Opción de Evaluación en Casa

Is the End of Recertification Exams Near? ABIM Announces At-Home Assessment Option

STICS: No Benefit to Perioperative Statin Therapy in Cardiac Surgery, but Acute Kidney Injury Risk Increased

BIOTRONIK Announces FDA Approval of MR Conditional Cardiac Resynchronization Defibrillators

The Heart Team: What Works, What Doesn’t, and What the Future Holds

Un Estudio del Mundo Real Confirma los Efectos de Apixaban y Rivaroxaban en el Manejo de la FA

Real-World Study Largely Confirms Effects of Apixaban, Rivaroxaban for A-fib

Low BMI in and of Itself Portends Poor Survival After Acute MI

Good Warfarin Management Prevents Complications in A-fib Patients, Swedish Study Contends

We Asked, You Answered: The Heart Team by the Numbers

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content